Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 12

Telogen effluvium: a comprehensive review

Authors Rebora A

Received 7 February 2019

Accepted for publication 7 May 2019

Published 21 August 2019 Volume 2019:12 Pages 583—590

DOI https://doi.org/10.2147/CCID.S200471

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Jeffrey Weinberg


Alfredo Rebora

University of Genoa, Genoa, Italy

Correspondence: Alfredo Rebora
Clinica Dermatologica, 7, Viale Benedetto XV, Genova 16132, Italy
Tel +3 901 0353 8417
Email rebdermo@yahoo.it

Abstract: Excessive hair shedding is a common and alarming phenomenon, usually complained about by women. The disorder, named telogen effluvium (TE), bears several problems which are discussed in this essay. They are as follows: 1) how profuse a hair loss must be for TE to be diagnosed; 2) its heterogeneity that needs to be properly classified; 3) its distinction from androgenetic alopecia (AGA) with which it is often associated; 4) its main symptom, trichodynia, which is unclear how frequent and how diagnostic could be; 5) why histopathology has been reported to be nonspecific; and 6) its management, from diagnosis to treatment. A common mistake of the dermatologist is to minimize the complaint. Instead, the disorder may have a profound impact on the patients’ mind and would require attention, time, and empathy.

Keywords: telogen effluvium, hair, alopecia


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]